EP2782551A1 - Compositions déodorantes - Google Patents

Compositions déodorantes

Info

Publication number
EP2782551A1
EP2782551A1 EP12791151.9A EP12791151A EP2782551A1 EP 2782551 A1 EP2782551 A1 EP 2782551A1 EP 12791151 A EP12791151 A EP 12791151A EP 2782551 A1 EP2782551 A1 EP 2782551A1
Authority
EP
European Patent Office
Prior art keywords
weight
menthol
composition
group
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12791151.9A
Other languages
German (de)
English (en)
Inventor
Thomas Dr. Döring
Gertraud Teckenbrock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2782551A1 publication Critical patent/EP2782551A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Definitions

  • the present application relates to cosmetic compositions which are suitable for deodorizing the body and for reducing body odor, in particular in the axillary area and / or in the area of the feet.
  • a further object was to provide a deodorizing composition which effectively reduces body odor, especially in the axillary area and / or around the feet, and has a pleasant but not too strong inherent odor.
  • the low odor of the active ingredient combination makes it possible to combine them with a larger selection of fragrances.
  • a further object was to provide a deodorizing composition which effectively reduces body odor, especially in the axillary area and / or around the feet, while using well-tolerated, side-effect-free active ingredients.
  • the present application therefore relates to cosmetic compositions for use as deodorants, comprising the components a) to d),
  • a cosmetically acceptable carrier comprising at least one component selected from ethanol, a liquid under normal conditions cosmetic oil and talc and mixtures thereof, and optionally other excipients, auxiliaries and active ingredients, wherein the wt .-% - information on refer to the total weight of the composition, without taking into account any existing propellant.
  • the substituent R of the at least one alkoxybenzene compound of the structural formula (I) is selected from a C 1 -C 8 -alkyl group, methyl group, ethyl group, n-propyl group, 2-methylethyl group, n-butyl group, n-hexyl group, 2-ethylhexyl group and an n-octyl group.
  • Particular preference is given to compositions according to the invention and those used according to the invention in which the at least one alkoxybenzene compound having the structural formula (I) is selected from compounds in which R represents a methyl group or an ethyl group, particularly preferably a methyl group.
  • the substituent R 2 of the at least one alkoxybenzene compound of structural formula (I) is selected from an ethyl group, an n-propyl group, a 1-methylethyl group, a n-butyl group, a 1-propenyl group and a 2-propenyl.
  • Particular preference is given to compositions according to the invention and those used according to the invention in which the at least one alkoxybenzene compound having the structural formula (I) is selected from compounds in which R 2 represents a 1-propenyl group.
  • Further inventively particularly preferred and preferably used compositions are characterized in that the at least one compound having the structural formula (I) is selected from compounds in which R is a methyl group and R 2 is a 1-propenyl group.
  • the substituents OR and R 2 of the alkoxybenzene compound of structural formula (I) may be ortho, meta and para to each other.
  • Particularly preferred compositions according to the invention and used according to the invention are characterized in that the at least one alkoxybenzene compound having the structural formula (I) is selected from those compounds in which the substituents OR 1 and R 2 are in para position to one another.
  • Further inventively particularly preferred and used in the invention compositions are characterized in that the at least one compound having the structural formula (I) is selected from compounds in which R is a methyl group and R 2 is a 1-propenyl, wherein the substituents OR 1 and R 2 in para-position to each other.
  • These compounds are particularly preferably selected from trans-anethol and from mixtures of cis-anethol and trans-anethol which, based on their weight, at most 1% by weight, preferably kart maximum of 0.5 wt .-% cis-anethole.
  • compositions according to the invention and used according to the invention comprise at least one alkoxybenzene compound of structural formula (I) in a total amount of 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1- 0.4 wt .-%, wherein the wt .-% - based on the total weight of the composition, without taking into account any existing propellant.
  • Compositions preferred and preferably used in accordance with the invention contain from 0.01 to 1% by weight, preferably from 0.04 to 0.6% by weight, particularly preferably from 0.1 to 0.4% by weight, of trans-anethol, the Wt .-% - refer to the total weight of the composition, without taking into account any existing propellant.
  • compositions according to the invention and used according to the invention further contain at least one compound selected from cyclic monoterpene epoxides in a total amount of 0.01-1% by weight and menthol in a total amount from 0.09 to 5% by weight, as well as from mixtures of these components, that is to say mixtures of 0.01 to 1% by weight of cyclic monoterpene epoxide (s) and 0.09 to 5% by weight.
  • Menthol, where the wt .-% information refers to the total weight of the composition, without taking into account any existing propellant.
  • Another preferred cyclic monoterpene epoxide is transcarvone-1, 2-epoxide, which is available from the orchid genus Catasetum.
  • compositions are characterized in that at least one cyclic monoterpene epoxide in a total amount of 0.02-0.5 wt .-%, preferably 0.05-0.2 wt .-%, particularly preferably 0 , 1 - 0.15 wt .-%, wherein the wt .-% - based on the total weight of the composition, without taking into account any existing propellant.
  • compositions according to the invention comprise 0.01-1% by weight, preferably 0.02-0.5% by weight, more preferably 0.05-0.2% by weight, most preferably 0.1 0.15% by weight of eucalyptol, the weight percentages being based on the total weight of the composition, without taking account of any propellant present.
  • Further preferred and preferably used compositions according to the invention comprise 0.01-1% by weight, preferably 0.02-0.5% by weight, more preferably 0.05-0.2% by weight, most preferably 0.1% - 0, 15 wt .-%, 1, 4-cineole, wherein the wt .-% - based on the total weight of the composition, without taking into account any existing propellant.
  • compositions according to the invention comprise 0.01-1% by weight, preferably 0.02-0.5% by weight, more preferably 0.05-0.2% by weight, most preferably 0.1 - 0, 15 wt .-%, a mixture of eucalyptol and 1, 4-cineole, wherein the wt .-% - refer to the total weight of the composition, without taking into account any existing propellant.
  • compositions preferred and preferably used according to the invention comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-0.4% by weight, of trans-anethol and 0, 01 - 1 wt .-%, preferably 0.02 - 0.5 wt .-%, particularly preferably 0.05 - 0.2 wt .-%, most preferably 0, 1 - 0, 15 wt .-%, eucalyptol , where the wt .-% - information refers to the total weight of the composition, without taking into account any existing propellant.
  • compositions preferred and preferred according to the invention are characterized in that the menthol is selected from L-menthol, D-menthol and DL-menthol, preferably selected from DL-menthol.
  • Further compositions preferred and preferably used according to the invention comprise 0.09-5% by weight, preferably 0.1-2.5% by weight, particularly preferably 0.25-1.8% by weight, most preferably 0.5-1.0% by weight, of menthol selected from L-menthol, D-menthol and DL-menthol, where the % Information on the total weight of the composition, without taking into account any existing propellant.
  • compositions according to the invention contain from 0.01 to 1% by weight, preferably from 0.04 to 0.6% by weight, more preferably from 0.1 to 0.4% by weight, of trans-anethole and from 0.09 to 5 Wt .-%, preferably 0, 1 to 2.5 wt .-%, particularly preferably 0.25 to 1, 8 wt .-%, most preferably 0.5 to 1, 0 wt .-% menthol, wherein the Wt .-% - refer to the total weight of the composition, without taking into account any existing propellant.
  • compositions according to the invention comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-1.4% by weight of trans-anethole and 0.09% 5 wt .-%, preferably 0, 1 - 2.5 wt .-%, particularly preferably 0.25 - 1, 8 wt .-%, most preferably 0.5 - 1, 0 wt .-% DL-menthol, where the wt .-% information refers to the total weight of the composition, without taking into account any existing propellant.
  • compositions which are particularly preferred according to the invention and are particularly preferably used contain 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-0.4% by weight, of trans-anethole, 0.01-1% by weight, preferably 0.02-0.5% by weight, more preferably 0.05-0.2% by weight, most preferably 0-1-0.0% by weight , Eucalyptol and 0.09 to 5 wt .-%, preferably 0, 1 to 2.5 wt .-%, particularly preferably 0.25 to 1, 8 wt .-%, most preferably 0.5 to 1, 0 wt % Menthol, the weight percentages being based on the total weight of the composition, without taking into account any propellant present.
  • compositions which are particularly preferred according to the invention and are particularly preferably used contain 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-0.4% by weight, of trans-anethole, 0.01-1% by weight, preferably 0.02-0.5% by weight, more preferably 0.05-0.2% by weight, most preferably 0-1-0.0% by weight , Eucalyptol and 0.09 to 5 wt .-%, preferably 0, 1 to 2.5 wt .-%, particularly preferably 0.25 to 1, 8 wt .-%, most preferably 0.5 to 1, 0 wt % DL-menthol, where the weight percentages refer to the total weight of the composition, without considering any propellant present.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 1 to menthol in the range of 1: 0.8 to 1: 10, preferably 1: 1 to 1: 7, more preferably 1: 2 to 1: 4.
  • compositions according to the invention are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 2 to menthol in the range from 1: 0.8 to 1:10, preferably 1: 1 to 1: 7, more preferably 1: 2 to 1: 4.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds with of the structural formula (I) according to claim 3 to menthol in the range of 1: 0.8 to 1:10, preferably 1: 1 to 1: 7, more preferably 1: 2 to 1: 4.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 4 to menthol in the range of 1: 0.8 to 1:10, preferably 1: 1 to 1: 7, more preferably 1: 2 to 1: 4.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 1 to cyclic monoterpene epoxides in the range of 1: 0.2 to 1: 1.1, preferably 1 : 0.5 to 1: 1, more preferably 1: 0.6 to 1: 0.8.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 2 to cyclic monoterpene epoxides in the range of 1: 0.2 to 1: 1.1, preferably 1 : 0.5 to 1: 1, more preferably 1: 0.6 to 1: 0.8.
  • compositions according to the invention are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 3 to cyclic monoterpene epoxides in the range of 1: 0.2 to 1: 1.1, preferably 1 : 0.5 to 1: 1, more preferably 1: 0.6 to 1: 0.8.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 4 to cyclic monoterpene epoxides in the range of 1: 0.2 to 1: 1.1, preferably 1 : 0.5 to 1: 1, more preferably 1: 0.6 to 1: 0.8.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 1 to the sum of cyclic monoterpene epoxides and menthol in the range of 1: 1 to 1:10, preferably 1 : 2 to 1: 7, more preferably 1: 4 to 1: 6.
  • compositions are characterized in that the weight ratio of all alkoxybenzene compounds having the structural formula (I) according to claim 3 to the sum of cyclic monoterpene epoxides and menthol in the range of 1: 1 to 1:10, preferably 1 : 2 to 1: 7, more preferably 1: 4 to 1: 6.
  • compositions which are particularly preferred according to the invention and are preferably used comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, more preferably 0.1-1.4% by weight, of trans-anethole and 0 , 09-5 wt .-%, preferably 0, 1 - 2.5 wt .-%, particularly preferably 0.25 - 1, 8 wt .-%, most preferably 0.5 - 1, 0 wt .-% DL Menthol, wherein the weight percentages are based on the total weight of the composition, without taking into account any propellant which may be present, the weight ratio of trans-anethole to menthol being in the range from 1: 0.8 to 1:10, preferably 1: 1 to 1: 7, more preferably 1: 2 to 1: 4.
  • compositions which are particularly preferred according to the invention and are preferably used comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-1.4% by weight, of trans-anethole, 0 , 01- 1 wt .-%, preferably 0.02 - 0.5 wt .-%, particularly preferably 0.05 - 0.2 wt .-%, most preferably 0, 1 - 0, 15 wt .-%, Eucalyptol and 0.09-5% by weight, preferably 0.1-2.5% by weight, more preferably 0.25-1.8% by weight, most preferably 0.5-1.0% by weight.
  • % DL-menthol where the weight percentages are based on the total weight of the composition, without considering any propellant present, the weight ratio of trans-anethole to menthol being in the range of 1: 0.8 to 1: 10, preferably 1: 1 to 1: 7, more preferably 1: 2 to 1: 4.
  • compositions which are particularly preferred according to the invention and are preferably used comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, more preferably 0.1-1.4% by weight, of trans-anethole and 0 , 01- 1 wt .-%, preferably 0.02 - 0.5 wt .-%, particularly preferably 0.05 - 0.2 wt .-%, most preferably 0, 1 - 0, 15 wt .-%, Eucalyptol, wherein the weight percentages are based on the total weight of the composition, without considering any propellant present, the weight ratio of trans-anethole to eucalyptol being in the range of 1: 0.2 to 1: 1, 1, preferably 1: 0.5 to 1: 1, more preferably 1: 0.6 to 1: 0.8.
  • compositions which are particularly preferred according to the invention and are preferably used comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-1.4% by weight, of trans-anethole, 0 , 01- 1 wt .-%, preferably 0.02 - 0.5 wt .-%, particularly preferably 0.05 - 0.2 wt .-%, most preferably 0, 1 - 0, 15 wt .-%, Eucalyptol and 0.09-5% by weight, preferably 0.1-2.5% by weight, more preferably 0.25-1.8% by weight, most preferably 0.5-1.0% by weight.
  • % DL-menthol the weight percentages being based on the total weight of the composition, without taking account of any propellant present, the weight ratio of trans-anethole to eucalyptol being in the range of 1: 0.2 to 1: 1, 1, preferably 1: 0.5 to 1: 1, more preferably 1: 0.6 to 1: 0.8, is located.
  • compositions which are particularly preferred according to the invention and are preferably used comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-1.4% by weight, of trans-anethole, 0 , 01- 1 wt .-%, preferably 0.02 - 0.5 wt .-%, particularly preferably 0.05 - 0.2 wt .-%, most preferably 0, 1 - 0, 15 wt .-%, Eucalyptol and 0.09-5% by weight, preferably 0.1-2.5% by weight, more preferably 0.25-1.8% by weight, most preferably 0.5-1.0% by weight.
  • the weight% information is based on the total weight of the composition without taking into account any propellant present, the weight ratio of menthol to eucalyptol being in the range from 1: 1 to 10: 1, preferably 2: 1 to 8: 1, particularly preferably 3: 1 to 5: 1, lies.
  • compositions which are particularly preferred according to the invention and are preferably used comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-1.4% by weight, of trans-anethole, 0 , 01- 1 wt .-%, preferably 0.02 - 0.5 wt .-%, particularly preferably 0.05 - 0.2 wt .-%, most preferably 0, 1 - 0, 15 wt .-%, Eucalyptol and 0.09-5% by weight, preferably 0.1-2.5% by weight, more preferably 0.25-1.8% by weight, most preferably 0.5-1.0% by weight.
  • % DL-menthol where the wt% data refer to the total weight of the composition, without considering any propellant present, the weight ratio of menthol to eucalyptol being in the range of 1: 1 to 20: 1, preferably 5 : 1 to 15: 1, more preferably 7: 1 to 10: 1.
  • compositions which are particularly preferred according to the invention and are preferably used comprise 0.01-1% by weight, preferably 0.04-0.6% by weight, particularly preferably 0.1-1.4% by weight, of trans-anethole, 0 , 01- 1 wt .-%, preferably 0.02 - 0.5 wt .-%, particularly preferably 0.05 - 0.2 wt .-%, most preferably 0, 1 - 0, 15 wt .-%, Eucalyptol and 0.09-5% by weight, preferably 0.1-2.5% by weight, more preferably 0.25-1.8% by weight, most preferably 0.5-1.0% by weight.
  • % DL-menthol where the weight percentages are based on the total weight of the composition, without taking account of any propellant present, the weight ratio of trans-anethole to the sum of eucalyptol and menthol in the range of 1: 1 to 1: 10, preferably 1: 2 to 1: 7, more preferably 1: 4 to 1: 6, is located.
  • compositions according to the invention contain 0 to 7% by weight, preferably 0 to 5% by weight, more preferably 0 to 3% by weight, even more preferably 0 to 1% by weight of water, in each case based on the weight of the composition, without taking into account any propellant contained.
  • Compositions used according to the invention to reduce body odor of the armpit and / or the feet contain 0 to 90% by weight, preferably 3 to 80% by weight, more preferably 5 to 75% by weight, most preferably 10 to 70% by weight.
  • % Water more preferably 30 to 60 wt .-% and in particular 40 to 55 wt .-% water, in each case based on the weight of the composition used in the invention, without taking into account if any propellant.
  • the compositions used according to the invention comprise 10 to 90% by weight, preferably 25 to 80% by weight, more preferably 30 to 75% by weight, more preferably 40 to 70% by weight and in particular 50 to 65 wt .-% water and at least one water-soluble polyol from the group of polyols having 2 to 9 carbon atoms and 2 to 6 hydroxyl groups in a total amount of 1 - 40 wt .-%, preferably 2 - 25 wt .-%, more preferably 4-15% by weight and in particular 5-10% by weight, in each case based on the weight of the composition used according to the invention, without any propellant present to take into account.
  • Preferred water-soluble polyols from the group of polyols having 2 to 9 C atoms and 2 to 6 hydroxyl groups which are not 1, 2-hexanediol and not 1, 2-octanediol are selected from 1, 2-propanediol, diethylene glycol, 2 Methyl-1,3-propanediol, glycerol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 1,2-pentanediol, 1,5-pentanediol, 1,6-hexanediol, 1, 2,6-hexanetriol, dipropylene glycol, tripropylene glycol, diglycerol, triglycerol, polyglycerol, erythritol, sorbitol, methylglucoside, butylglucoside, trans-1,4-dimethylolcyclohexane, cis-1,4-d
  • compositions used according to the invention comprise 10 to 90% by weight, preferably 25 to 80% by weight, more preferably 30 to 75% by weight, more preferably 40 to 70% by weight and in particular 50 to 65 wt .-% water and ethanol in an amount of 1-90 wt .-%, preferably 5-85 wt .-%, particularly preferably 10-75 wt .-%, most preferably 20 - 50 wt .-%, respectively based on the weight of the composition used in the invention, without taking into account any propellant contained.
  • compositions of the present invention comprise a cosmetically acceptable carrier comprising at least one component selected from ethanol, a liquid cosmetic oil and talc under normal conditions, and mixtures thereof.
  • compositions used according to the invention comprise a cosmetically acceptable carrier which comprises at least one component selected from water, ethanol, a liquid cosmetic oil and talc under normal conditions and mixtures thereof.
  • the compositions according to the invention contain 0 to 5% by weight, preferably 0 to 3% by weight, more preferably 0 to 1% by weight, of water, and ethanol in an amount of 1 to 90% by weight. , preferably 5 to 85 wt .-%, particularly preferably 10 to 75 wt .-%, most preferably 25 to 60 wt .-%, each based on the weight of the composition, without taking into account any propellant contained.
  • normal conditions are a temperature of 20 ° C. and a pressure of 1013.25 mbar. Melting point data likewise relate to a pressure of 1013.25 mbar.
  • the total amount of cosmetic oils which are liquid under normal conditions is 1 to 95% by weight, preferably 5 to 90% by weight, more preferably 30 to 75% by weight, most preferably 50 to 60% by weight, of compositions preferred and preferably used according to the invention. -%, wherein the quantities are based on the weight of the composition, without taking into account any existing propellant.
  • Non-volatile oils are understood as meaning oils having a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C and an ambient pressure of 1013 hPa.
  • Volatile oils are understood to mean those oils which, at 20 ° C. and an ambient pressure of 1013 hPa, produce a vapor pressure of 2.66 Pa - 40,000 Pa (0.02 mm - 300 mm Hg), preferably 13-12000 Pa (0.1-90 mm Hg), more preferably 15-8000 Pa, most preferably 200-3000 Pa
  • Volatile cosmetic oils are usually selected from cyclic silicone oils with the INCI name Cyclomethicone.
  • cyclomethicones is understood in particular to mean cyclotrisiloxane (hexamethylcyclotrisiloxane), cyclotetrasiloxane (octamethylcyclotetrasiloxane), cyclopentasiloxane (decamethylcyclopentasiloxane) and cyclohexasiloxane (dodecamethylcyclohexasiloxane).
  • These oils have a vapor pressure of about 13-15 Pa at 20 ° C.
  • Cyclomethicones are known in the art as well-suited oils for cosmetic compositions, especially for deodorizing compositions such as sprays and sticks. Due to their persistence in the environment, it may be preferred according to the invention to dispense with the use of cyclomethicones.
  • the compositions according to the invention and used according to the invention contain from 0 to less than 1% by weight of cyclomethicones, based on the weight of the composition, whereby any propellant present is not taken into account.
  • volatile silicone oils are selected from volatile linear silicone oils, in particular volatile linear silicone oils having 2-10 siloxane units, such as hexamethyldisiloxane (L 2 ), octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ), as described e.g. B. in the commercial products DC 2-1 184, Dow Corning ® 200 (0.65 cSt) and Dow Corning ® 200 (1, 5 cSt) by Dow Corning, and low molecular weight phenyl trimethicone having a vapor pressure at 20 ° C of about 2000 Pa, such as that available from GE Bayer Silicones / Momentive under the name Baysilone Fluid PD 5.
  • volatile linear silicone oils in particular volatile linear silicone oils having 2-10 siloxane units, such as hexamethyldisiloxane (L 2 ), octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (
  • compositions according to the invention contain at least one volatile non-silicone oil because of the drier skin feel.
  • Preferred volatile non-silicone oils are selected from C 8 -C 6 -isoparaffins, in particular from isononane, isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, and isohexa-decane, and mixtures thereof.
  • Preference is given to Ci 0 -Ci 3 isoparaffin mixtures in particular those having a vapor pressure at 20 ° C of about 300-400 Pa, preferably 360 Pa.
  • This at least one C 8 -C 16 iso-paraffin is preferably in a total amount of 25-50 wt.%, Preferably 30-45 wt.%, More preferably 32-40 wt.%, Most preferably 34-37 wt. -%, in each case based on the total propellant-free composition included.
  • the at least one oil which is liquid under normal conditions comprises at least one volatile C 8 -C 6 -isoparaffin, in particular isononane, isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and isohexadecane and mixtures thereof.
  • compositions according to the invention comprise at least one nonvolatile cosmetic oil selected from nonvolatile silicone oils and non-volatile non-silicone oils.
  • Residues of carrier insoluble components such as Antiperspirant active agents or talc can be successfully masked with a nonvolatile oil.
  • parameters such as skin feel, residue visibility and stability of the composition of the invention can be finely regulated and better adapted to consumer needs.
  • compositions according to the invention and used according to the invention with a low proportion of volatile oils - that is, with 0.5 - 24.5 wt .-% of volatile oils, based on the weight of the blowing agent-free composition - or even without volatile To formulate oils.
  • these esters which are solid under normal conditions, do not constitute cosmetic oils, since they do not fulfill the condition "liquid under normal conditions."
  • the assignment as to whether such an ester is liquid or solid under normal conditions is within the skill of the art linear or branched saturated fatty alcohols having 2 to 5 carbon atoms with linear or branched saturated or unsaturated fatty acids having 3 to 18 carbon atoms which may be hydroxylated Preferred examples thereof are isopropyl palmitate, isopropyl stearate, isopropyl myristate, 2-hexyldecyl stearate, 2-hexyldecyl laurate, isononyl isononanoate, 2 Also preferred are isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethyl
  • 2-alkanols Particular preference is given to benzoic acid C 12 -C 15 -alkyl esters, eg. B. available as a commercial product Finsolv ® TN (C 12 -C 15 alkyl benzoate), and isostearyl benzoate, z.
  • Finsolv ® SB 2-ethylhexyl
  • z. B. available as Finsolv ® EB
  • benzoic acid 2-octyldocecylester As available as Finsolv ® BOD.
  • Further non-volatile non-silicone oils which are preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms.
  • Alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred alcohol oils are 2-hexyldecanol, 2-octyldodecanol and 2-ethylhexyl alcohol. Also preferred is isostearyl alcohol.
  • Other preferred nonvolatile oils are selected from mixtures of Guerbet alcohols and Guerbet alcohol esters, e.g. B. 2-hexyl decanol and 2-hexyldecyl laurate.
  • triglyceride used hereinafter means “glycerol triester”.
  • Further preferred nonvolatile oils according to the invention are selected from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 -3o-fatty acids, provided that they are liquid under normal conditions.
  • Particularly suitable may be the use of natural oils, eg soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Commercial products Myritol ® 318 or Myritol ® 331 (BASF / Cognis) with unbranched fatty acid residues and glyceryl triisostearin and glyceryl tri (2-ethylhexanoate) with branched fatty acid residues.
  • Such triglyceride oils preferably account for less than 50% by weight of the total weight of all cosmetic oils in the composition of the invention.
  • the total weight of triglyceride oils 0.5 to 10 wt .-%, preferably 1-5 wt .-%, each based on the total composition, without taking into account any existing propellant.
  • non-volatile non-silicone oils are selected from the dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols, especially di- isopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di- n-butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di- (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols especially di- isopropyl adipate, di-n-butyl adipate, di-
  • non-volatile non-silicone oils are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 -22-alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. PPG-2 myristyl ether and PPG-3 myristyl ether.
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C 3 .
  • 2-alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for. PPG-14 butyl ether, PPG-9 butyl ether, PPG-10-butanediol, PPG-15 stearyl ether and glycereth-7-diisononanoate.
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the symmetrical, unsymmetrical or cyclic esters of carbonic acid with C 6 -C 20 -alcohols, eg. As di-n-caprylylcarbonat (Cetiol ® CC) or di- (2-ethylhexyl) carbonate (Tegosoft DEC).
  • Esters of carbonic acid with C 1 -C 8 -alcohols eg. As glycerol carbonate or propylene carbonate, however, are not suitable as a cosmetic oil compounds.
  • the total weight of dimer fatty acid esters is particularly preferably 0.5-10 wt. %, preferably 1 - 5 wt .-%, each based on the total composition, without taking into account any existing propellant
  • Compositions according to the invention and used according to the invention can also be formulated as deodorizing body powders.
  • the main ingredient of such carriers is talc.
  • Body powders according to the invention and used according to the invention can be present as loose powder or as compact powder.
  • the powder base for loose powders usually comprises at least 70 wt .-% talc, 2 - 10 wt .-% metal soaps, in particular the stearates of magnesium, zinc, titanium, calcium and aluminum, preferably magnesium stearate, besides other powdered ingredients selected from silica , Starch, titanium dioxide, zinc dioxide, kaolin, calcium carbonate and magnesium carbonate.
  • Compact powders usually contain talc in amounts of less than 70% by weight, for example 5-60% by weight, and in addition oils and / or waxes in an amount of 2-15% by weight.
  • compositions according to the invention and used according to the invention optionally contain further excipients, auxiliaries and active substances.
  • compositions according to the invention and those used according to the invention contain, in addition to the active ingredient combination according to the invention, as further deodorizing active ingredient at least one aromatic alcohol of the structure (AA-1),
  • the radicals R to R 6 independently of one another represent a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, which may be linear or branched and substituted with OH groups or alkoxy groups having 1 to 5 carbon atoms,
  • radicals R 7 to R independently of one another are a hydrogen atom, a halogen atom, in particular a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, in particular with a methoxy group,
  • compositions according to the invention and used according to the invention contain at least one alcohol AA-1, as described above, which is selected from anisalcohol, 2-methyl-5-phenyl-pentan-1-ol, 1, 1-dimethyl-3-phenyl-propane -1-ol, benzyl alcohol, 2-phenylethan-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2 , 2-dimethyl-3-phenylpropan-1-ol, 2,2-dimethyl-3- (3'-methylphenyl) -propane
  • alcohol AA-1 as described above, which is selected from anisalcohol, 2-methyl-5-phenyl-pentan-1-ol, 1, 1-dimethyl-3-phenyl-propane -1-ol, benzyl alcohol, 2-phenylethan-1-ol, 3-phenylpropan-1-ol
  • compositions according to the invention and used according to the invention comprise at least one alcohol AA-1, as described above, in a total amount of 0.05-10% by weight, preferably 0.1-1.5% by weight, more preferably 0.2 - 2 wt .-%, most preferably 0.3 - 1, 5 wt .-%, each based on the weight of the composition, without taking into account any propellant contained.
  • compositions according to the invention and used according to the invention are characterized by a content of the deodorizing agent 3- (2-ethylhexyloxy) -1,2-propanediol, preferably in a total amount of 0.05-5% by weight, preferably 0.1 - 2 wt .-%, more preferably 0.2 to 1, 5 wt .-%, most preferably 0.5 to 1, 0 wt .-%, each based on the weight of the composition, without taking into account any propellant contained ,
  • compositions according to the invention and used according to the invention are characterized by a content of tropolone (2-hydroxy-2,4,6-cycloheptatrienone), preferably in an amount of 0.001-0.1% by weight, based on the weight the composition, without taking into account any propellant contained.
  • compositions according to the invention and used according to the invention are characterized by a content of 1, 2-hexanediol and / or 1, 2-octanediol as highly effective deodorant active ingredients, which do not disturb the microbial balance of the healthy skin.
  • Preferred inventive and inventively used deodorant compositions contain 0, 1-10 wt .-% 1, 2-hexanediol and / or 0.1 to 10 wt .-% 1, 2-octanediol, each based on the weight of the composition, without included propellant.
  • Particularly preferred deodorant compositions according to the invention contain 0.1 to 5% by weight, preferably 0.2 to 1% by weight, of 1, 2-hexanediol and / or 0.1 to 5% by weight, preferably 0.2 to 1% by weight .-% 1, 2-octanediol, each based on the weight of the composition, without taking into account if any propellant.
  • Extremely preferred deodorant compositions according to the invention and used according to the invention contain 0.2 - 0.5% by weight of 1,2-hexanediol and 0.2-0.5% by weight of 1,2-octanediol, in each case based on the weight of the composition, without consideration of any propellant present.
  • compositions according to the invention and used according to the invention are characterized by a content of triethyl citrate.
  • Triethyl citrate is a known deodorant active which acts as an enzyme inhibitor for esterases and lipases and thus contributes to the broadband effect of preferred compositions according to the invention.
  • Preferred compositions according to the invention and used according to the invention contain 0.5 to 15% by weight, preferably 3 to 8% by weight, very preferably 4 to 6% by weight, in each case based on the weight of the composition, without any propellant present consider.
  • compositions according to the invention and used according to the invention are characterized by a content of at least one cationic phospholipid of the formula KPL,
  • R 2 and R 3 are alkyl groups having 1 to 4 C atoms or hydroxyalkyl groups having 2 to 4 C atoms or carboxyalkyl groups of the formula - (CH 2 ) z -COOM, wherein z has a value of 1 to 3 and M is hydrogen or a Alkali metal cation,
  • x has a value of 1 to 3 and y has a value of (3 - x), M is hydrogen or an alkali metal cation and A "is an anion.
  • Preferred alkyl groups having 8 to 22 C atoms are selected from an n-octyl, n-nonyl, n-decyl, n-undecyl, lauryl, n-tridecanyl, myristyl, n-pentadecanyl, cetyl , Palmityl, stearyl, elaidyl, arachidyl, behenyl and a cocyl group.
  • a representative cocyl group consists, based on their total weight, of 4-9% by weight of n-octyl, 4-9% by weight of n-decyl, 45-55% by weight of lauryl, 15-21 % By weight of myristyl, 8-13% by weight of palmityl and 7-14% by weight of stearyl groups.
  • Preferred alkenyl groups having 8 to 22 C atoms are selected from a linoleyl group ((9Z, 12Z) -Octadeca-9, 12-dien-1-yl) and a linolenyl group ((9Z, 12Z, 15Z) octadeca - 9, 12, 15-trien-1-yl).
  • a preferred hydroxyalkyl group having 8 to 22 C atoms is selected from a 12-hydroxystearyl group.
  • Preferred linear acyl groups R 5 CO having 8 to 22 C atoms are selected from an n-octanoyl, n-nonanoyl, n-decanoyl, n-undecanoyl, lauroyl, n-tridecanoyl, myristoyl, n-Pentadecanyl, Cetoyl, Palmitoyl, Stearoyl, Elaidoyl, Arachidoyl, Behenoyl and a Cocoyl group.
  • a representative cocoyl group consists, based on their total weight, of 4-9% by weight of n-octanoyl, 4-9% by weight of n-decanoyl, 45-55% by weight of lauroyl, 15-21 % By weight of myristoyl, 8-13% by weight of palmitoyl and 7-14% by weight of stearoyl groups.
  • Particularly preferred linear acyl groups R 5 CO are selected from a cocoyl group, a lauroyl group (n-CnH 23 CO), a myristoyl group (n-Ci 3 H 27 CO) and a linoleoyl group ((9Z, 12Z ) Octa-deca-9,12-dien-1-oyl).
  • Exceptionally preferred linear acyl groups R 5 CO are selected from a cocoyl group, a lauroyl group (n-CiiH 23 CO) and a myristoyl group (nC 13 H 27 CO).
  • Preferred alkyl groups having 1 to 4 C atoms are a methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 2-methylpropyl and a tert-butyl group. Particularly preferred is the methyl group.
  • Preferred hydroxyalkyl groups having 2-4 C atoms are a 2-hydroxyethyl and a 1-hydroxyethyl group.
  • Preferred alkali metal cations are selected from sodium and potassium cations; Na + is particularly preferred.
  • Preferred anions are selected from sulfate, chloride, phosphate, nitrate, bicarbonate and acetate, with a chloride anion being particularly preferred.
  • compositions according to the invention contain as deodorant active ingredient a cationic phospholipid of the formula KPL,
  • At least one cationic phospholipid of the formula KPL having the abovementioned features is present in a total amount of 0.05-2% by weight, preferably 0.1-1% by weight, more preferably 0.15-0.4% by weight. -%, in each case based on the weight of the composition, without taking into account any propellant contained.
  • compositions according to the invention comprise a cationic phospholipid of the formula KPL,
  • R is a cocoylaminopropyl group (also referred to as cocamidopropyl group)
  • R 2 and R 3 are methyl groups
  • x 2
  • y 1
  • M is a sodium ion
  • Cocamidopropyl PG-Dimonium Chloride Phosphate is available in a total amount of 0.05 to 2 wt .-%, preferably 0.1 to 1 wt .-%, particularly preferably 0, 15 to 0.4 wt .-%, each based on the weight of the composition , without taking into account any propellant contained.
  • compositions according to the invention and used according to the invention comprise a cationic phospholipid of the formula KPL,
  • R is a myristoylaminopropyl group
  • R 2 and R 3 are methyl groups
  • x 2
  • y 1
  • M is a sodium ion
  • compositions according to the invention comprise a cationic phospholipid of the formula KPL,
  • R is a lauroylaminopropyl group
  • R 2 and R 3 are methyl groups
  • x 2
  • y 1
  • M is a sodium ion
  • compositions according to the invention and used according to the invention may also antiperspirant active substances, in particular antiperspirant aluminum salts and aluminum-zirconium salts.
  • Preferred antiperspirant actives are selected from aluminum salts, preferably from the water-soluble astringent inorganic and organic salts of aluminum and aluminum-zirconium mixtures. According to the invention, aluminosilicates and zeolites do not belong to the antiperspirant active ingredients.
  • water solubility is understood as meaning a solubility of at least 3% by weight at 20 ° C., that is to say that 3 g of the antiperspirant active are soluble in 97 g of water at 20 ° C.
  • antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al 2 (OH) 5 Cl. 1-6 H 2 O] n , preferably [Al 2 (OH) 5 Cl. 2-3 H 2 O. ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1-6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or in activated (depolymerized) form.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g.
  • KAI (S0 4 ) 2 ⁇ 2 H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 O, KAI (S0 4 ) 2 ⁇ 1 1 H 2 0 KAI (S0 4 ) 2 ⁇ 12 H 2 0 alum, partially hydrated alum or burnt alum), aluminum undecylenoyl- collagen amino acid, sodium aluminum lactate + aluminum sulphate, Sodium aluminum chloro hydroxylactate, aluminum bromohydrate, aluminum chloride, the aluminum salts of lipoamino acids, aluminum sulfate, aluminum lactate, aluminum
  • Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as “activated” aluminum and aluminum zirconium salts, which are also referred to as “enhanced activity” as antiperspirant active ingredients.
  • Active ingredients are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688.
  • Activated aluminum and aluminum zirconium salts are typically produced by heat treating a relatively dilute solution of the salt (eg, about 10% by weight salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum and aluminum zirconium salts typically have an HPLC peak 4 to peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks ,
  • Antiperspirant active ingredients which are likewise preferred according to the invention are nonaqueous solutions or solubilisates of an activated aluminum or aluminum zirconium antiperspirant salt, for example according to US 6010688, by adding an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups , preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC Peak 4: Peak 3 area ratio of the salt.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups preferably propylene glycol, sorbitol and pentaerythritol
  • compositions containing by weight 18-45% by weight of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol of 3 to 6 carbon atoms and 3 to 6 Hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
  • antiperspirant active substances are basic calcium aluminum salts, as disclosed, for example, in US Pat. No. 2,571,030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • antiperspirant active compounds are aluminum-zirconium complexes, as disclosed, for example, in US Pat. No. 4,017,599, which comprises salts of amino acids, in particular with Alkaline and Erdalkaliglycinaten, are buffered.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6,245,325 or US 6042816, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10 and a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight ratio of 1: 1-1: 28 and preferably 1: 2-1: 25.
  • USP activated aluminum or aluminum zirconium salts
  • an amino acid or hydroxyalkanoic acid in an amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10
  • a water-soluble calcium salt in such an amount as to provide Ca: (AI + Zr) weight
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • % preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight.
  • % preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore so much water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25 is, and so much glycine, that the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10 ,.
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight of molecularly bound water, furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and so much hydroxyalkanoic acid that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount as to provide a Sr : (Al + Zr) - weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1: 25 provide.
  • US 6902723 containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one Amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1 to 1:28, preferably 1: 2 to 1:25, and as much glycine, the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 to 13% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much hydroxyalkanoic acid, the hydroxyalkanoic acid is in the (Al + Zr) weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or N0 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2, 1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie, X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2..1: 1 ,
  • Preferred activated aluminum-zirconium salts are those which are mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) .p represent b Y b 2 wherein Y is Cl, Br, I, N0 3 or S0 4, b is a rational Number from 0.8 to 2 and p the valency of Y is as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride having the formula ZrO (OH) 2 -b Cl b , wherein b is a rational number of from 0.8 to 2, preferably from 1.0 to 1.9.
  • Preferred aluminum-zirconium salts have an Al: Zr molar ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 1.2, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum-zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • the term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.
  • water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-16% by weight, preferably 4-13% by weight of water of hydration.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • aluminum zirconium chlorohydrate-glycine salts which are stabilized with betaine ((CH 3 ) 3 N + -CH 2 -COO " ).
  • Particularly preferred corresponding compounds have a total molar (betaine + glycine) / Zr ratio of (0, 1 - 3.0): 1, preferably (0.7 - 1, 5): 1, and a betaine to glycine molar ratio of at least 0.001: 1.
  • Corresponding compounds are disclosed, for example, in US 7105691.
  • the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least at least 33%, more preferably at least 45%, based on the total area under peaks 2-5, measured by HPLC of a 10% by weight aqueous solution of the active ingredient under conditions in which the aluminum species is resolved into at least 4 consecutive peaks are (with peaks 2 - 5 designated).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content are disclosed, for example, in US 6436381 and US 6649152.
  • antiperspirant active ingredients are those aluminum zirconium salts having a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt.
  • Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • the antiperspirant active compounds can be used as nonaqueous solutions or as glycolic solubilisates. Preferably, however, the antiperspirant active ingredients are present in undissolved, suspended form.
  • antiperspirant active ingredients are suspended in a water-immiscible carrier and are undissolved, it is preferred for reasons of product stability that their particles have a number average particle size of 0.1-200 ⁇ , preferably 1-150 ⁇ , particularly preferably 3-100 ⁇ and most preferably 5 - 80 ⁇ , have. Further preferred antiperspirant active ingredient particles have a volume-average particle size of 0.2 to 220 ⁇ m, preferably 3 to 160 ⁇ m, more preferably 4 to 125 ⁇ m, more preferably 5 to 120 ⁇ m, and most preferably 10 to 80 ⁇ m.
  • Preferred antiperspirant aluminum-zirconium salts have a molar metal-to-chloride ratio of 0.9-1.5, preferably 0.9-1.3, more preferably 0.9-1.1.
  • Zirconium-free aluminum salts which are particularly preferred according to the invention have a molar metal-to-chloride ratio of 1.9 to 1.2.
  • Zirconium-free aluminum sesquichlorohydrates which are particularly preferred according to the invention have a molar metal-to-chloride ratio of 1.5: 1-1.8: 1.
  • compositions according to the invention and used according to the invention are characterized in that the at least one antiperspirant active ingredient in an amount of 3 to 35 wt .-%, preferably 5 to 30 wt .-% and particularly preferably 10 to 27 wt .-%, contain is, based on the total weight of the anhydrous active substance (USP) in the overall composition.
  • USP anhydrous active substance
  • the composition according to the invention or according to the invention contains an astringent aluminum salt, in particular aluminum chlorohydrate, particularly preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88% by weight, based on the raw material tel quel.
  • an astringent aluminum salt in particular aluminum chlorohydrate, particularly preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88% by weight, based on the raw material tel quel.
  • USP anhydrous active substance
  • Preferred non- activated aluminum chlorohydrates for example, in powder form as Micro Dry ® Ultrafine or Super Ultrafine from Reheis, Microdry 323 of Summit, as Chlorhydrol ® as well as in activated form as Reach ® 501 available from Reheis. Under the name Reach ® 301 is an aluminum (formerly Reheis) offered sesquichlorohydrat Summit, which is also particularly preferred.
  • Aluminum-zirconium-Tetrachlorohydrex-glycine complexes for example, by Summit (formerly Reheis) under the name Rezal ® 36 GP or AZG - 364 or 369 from Summit, in activated quality, as Reach ® 908, as a powder in Trade, may be particularly preferred according to the invention.
  • Aluminum-zirconium pentachlorohydroxy-glycine complexes (AAZG-3108 or AAZG-31 10 from Summit) are also preferred antiperspirant agents.
  • compositions according to the invention or used according to the invention are filled with a propellant in an aerosol dispenser.
  • Suitable propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1 , 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1-difluoroethane, both individually and in combination.
  • hydrophilic propellants such.
  • hydrophilic gases can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess.
  • propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants are particularly preferred.
  • compositions according to the invention or those used according to the invention contain at least one propellant which is selected from at least one compound having 3 to 10 carbon atoms according to formula (PROP-I)
  • radicals R, R 2 , R 3 and R 4 independently of one another represent a hydrogen atom, a bromine atom, a fluorine atom or a (C 1 -C 6 ) -alkyl group substituted by at least one fluorine atom,
  • R, R 2 , R 3 or R 4 is a hydrogen atom or a fluorine atom
  • At least one of the radicals R, R 2 , R 3 or R 4 is a (Ci to C 6 ) -alkyl group substituted by at least one fluorine atom or at least two of the radicals R, R 2 , R 3 and R 4 are a or form a six-membered ring.
  • POCP Photochemical Ozone Creation Potential
  • ODP ozone depletion potential
  • Preferred propellants according to formula (PROP-I) are selected from at least one compound having 3 to 10 carbon atoms according to the above formula (PROP-I), in which R, R 2 , R 3 or R 4 independently represent a hydrogen atom, a fluorine atom or a (Ci to C 6 ) alkyl group substituted with at least one fluorine atom, with the proviso that at least one of the radicals R, R 2 , R 3 or R 4 is a hydrogen atom or a fluorine atom, and at least one of the radicals R, R 2 , R 3 or R 4 is a substituted with at least one fluorine atom (Ci to C 6 ) alkyl group.
  • CF 3 CH CHC 2 F 5
  • C 2 F 5 CH CHC 2 F 5
  • CF 3 CH CHCF 2 CF 2 CF 3
  • CF 3 CF CFC 2 F 5
  • CF 3 CF CFCF 2 CF 2 CF 2 CF 3
  • C 2 F 5 CF CFCF 2 CF 2 CF 3
  • CF 3 CH CFCF 2 CF 2 CF 2 CF 3
  • CF 3 CF CHCF 2 CF 2 CF 2 CF 3
  • C 2 F 5 CH CFCH 2 CH 2 CH 3
  • C 2 F 5 CF CHCF 2 CF 2 CF 3
  • compositions are characterized in that non-fluorinated hydrocarbons having one to six carbon atoms in a total amount of 0 to 50 wt .-%, preferably 0 to 30% by weight, particularly preferably 0 to 10 wt .-%, in each case based on the weight of all propellants contained, are included.
  • compositions containing the blowing agent in an amount of 10 to 90 wt .-%, preferably 40 to 85 wt .-% and particularly preferably 50 to 80 wt .-%, each based on the total weight of the preparation from the components a) to d) and the blowing agent, are preferred according to the invention.
  • pressurized gas containers or spray cans vessels of metal (aluminum, tinplate, tin), protected or non-splitterndem plastic or of glass, which is coated on the outside with plastic, in question, in their selection print and Breaking strength, corrosion resistance, easy fillability as well as aesthetic aspects, handiness, printability etc. play a role.
  • Special internal protective lacquers ensure corrosion resistance to the compositions according to the invention.
  • compositions preferred or preferred according to the invention which contain an undissolved antiperspirant active, in particular an aluminum salt, suspended in an oleaginous carrier, such as antiperspirant rollons and propellant sprayable antiperspirant sprays, contain a suspending agent to stably suspend the undissolved ingredients selected from lipophilic thickeners.
  • an oleaginous carrier such as antiperspirant rollons and propellant sprayable antiperspirant sprays
  • Preferred lipophilic thickeners according to the invention are selected from hydrophobized clay minerals, in particular from hydrophobically modified hectorites and bentonites, as for example under the INCI names Disteardimonium Hectorite, Stearalkonium Hectorite, Stearalkonium Bentonite, Quaternium-18 Hectorite, Quaternium-18 Bentonite or Dihydrogenated Tallow Benzylmonium Hectorites are available.
  • the preferred or preferred compositions used according to the invention therefore comprise at least one hydrophobized clay mineral in a total amount of 0.5-10% by weight, preferably 1-7% by weight, more preferably 2-6% by weight, most preferably 3-10% by weight. 5 wt .-%, each based on the total weight of the blowing agent-free composition.
  • Such hydrophobized clay minerals usually require as activator water, ethanol or propylene carbonate in an amount of 0.3 to 3 wt .-%, preferably 0.5 to 2 wt .-%, each based on the total weight of the propellant-free composition according to the invention.
  • Further inventively preferred lipophilic thickeners are selected from pyrogenic silicas, eg. For example, the commercial products of the Aerosil ® series from Evonik Degussa. Particularly preferred are hydrophobized fumed silicas, most preferably silica silylates and silica dimethyl silylates.
  • compositions preferred or preferably used according to the invention are characterized in that they contain at least one fumed silica, preferably at least one hydrophobized fumed silica, in a total amount of 0.5-10% by weight, preferably 0.8-5% by weight. more preferably 1 to 4 wt .-%, most preferably 1, 5 to 2 wt .-%, each based on the total weight of the blowing agent-free composition of the invention.
  • compositions are characterized in that they contain at least one hydrophobized fumed silica and at least one hydrophilic silica.
  • compositions contain in addition to the active compounds a) and b) according to the invention at least one further fragrance.
  • a fragrance in the sense of the present application is in accordance with the expert definition as it can be found in the R ⁇ MPP Chemie Lexikon, as of December 2007.
  • a fragrance is a chemical compound with Odor and / or taste that excites hair cell receptors (adequate stimulus).
  • the necessary physical and chemical properties are a low molecular weight of at most 300 g / mol, a high vapor pressure, minimal water and high lipid solubility and weak polarity and the presence of at least one osmophoric group in the molecule.
  • fragrances according to the invention have a molecular weight of 74 to 300 g / mol, contain at least one osmophoric group in the molecule and have a smell and / or taste, that is, they excite the receptors of the hair cells of the olfactory system.
  • perfumes perfume oils, perfume oil constituents or individual perfume compounds.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg.
  • ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are e.g.
  • the ethers include z. Benzyl ethyl ether and ambroxan, to the aldehydes e.g.
  • the linear alkanals having 8-18 C atoms citral, citronellal, citronellyloxyacetaldehyde, cyclamenealdehyde, lilial and bourgeonal, to the ketones, e.g. the alcohols include citronellol, eugenol, geraniol, linalool, phenylethyl alcohol, alpha-terpineol, beta-terpineol, gamma-terpineol, and delta-terpineol; the hydrocarbons mainly include the terpenes such as limonene and pinene , Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance.
  • the alcohols include citronellol, eugenol, geraniol, linalool, phenylethyl alcohol, alpha-terpineol, beta-terpineol, gamma-terpineol
  • perfume oils may also contain natural fragrance mixtures such as are available from vegetable sources, e.g. Pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • natural fragrance mixtures such as are available from vegetable sources, e.g. Pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • Muscat sage oil chamomile oil, clove oil, lemon balm oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and labdanum oil as well as orange blossom oil, neroli oil, orange peel oil and sandalwood oil.
  • a fragrance In order to be perceptible, a fragrance must be volatile, whereby besides the nature of the functional groups and the structure of the chemical compound, the molecular weight also plays an important role. For example, most odorants have molecular weights up to about 200 daltons, while molecular weights of 300 daltons and above are more of an exception.
  • fragrances Due to the different volatility of fragrances, the odor of a perfume or fragrance composed of several fragrances changes during the evaporation, wherein the Olfactory impressions are divided into “top note”, “middle note or body” and “base note” (end note or dry out), since odor perception is also largely based on odor intensity
  • more volatile fragrances may be bound to certain fixatives, causing them to become too fast
  • the essential oils such as angelica may be useful in the present invention oil, aniseed oil, arnica blossom oil, basil oil, bay oil, bergamot oil, champa blossom oil, fir pine oil, pinecone oil, elemi oil, fennel oil, spruce needle oil, galbanum oil, geranium oil, ginger grass oil, guaiac
  • fragrances can be used in the context of the present invention as adherent fragrances or fragrance mixtures, ie fragrances.
  • These compounds include the following compounds and mixtures thereof: ambrettolide, allyl acetate, alpha-amylcinnamaldehyde, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, ethyl benzoate, benzophenone, benzyl alcohol, benzyl acetate, benzyl benzoate, benzyl formate, benzyl valerate, borneol , Bornyl acetate, alpha-bromostyrene, n-decyl aldehyde, n-dodecyl aldehyde, eugenol, eugenol methyl ether, farnesol,
  • the more volatile fragrances include in particular the lower-boiling fragrances of natural or synthetic origin, which can be used alone or in mixtures.
  • Examples of more readily volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, linalool, linalyl acetate, linalyl propionate, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.
  • compositions contain in addition to the active compounds a) and b) at least one other fragrance in a total amount of 0.00001 to 10 wt .-%, preferably 0.5 to 7 wt .-%, particularly preferably 1 - 5 wt .-%, wherein the wt .-% - refer to the total weight of the composition, without taking into account any existing propellant.
  • a further subject of the present application is the use of a cosmetic composition comprising the components a) to c),
  • a cosmetically acceptable carrier comprising at least one component selected from water, ethanol, an oil and talc and mixtures thereof, as well as optionally other excipients, auxiliaries and active substances,
  • compositions according to the invention applies mutatis mutandis, insofar as it does not relate to the water content of the compositions.
  • a further subject matter of the present application is a non-therapeutic, cosmetic method for reducing body odor, in which a cosmetic composition comprising the components a) to c),
  • a cosmetically acceptable carrier comprising at least one component selected from water, ethanol, an oil and talc and mixtures thereof, as well as optionally other excipients, auxiliaries and active substances,
  • compositions according to the invention applies insofar as it does not relate to the water content of the compositions.
  • An artificial sweat mixture was prepared by mixing different short-chain fatty acids in specific proportions (C6, C8, C9, C10, isovaleric acid). Of the drugs and drug combinations to be tested each 0.5 wt .-% solutions were prepared in ethanol, applied to filter paper in a standardized amount and dried for one hour at room temperature. The art sweat mixture was then applied in a standardized amount and the filters were kept in a closed container for 24 hours at room temperature.
  • the odor evaluation of the samples was performed by 6 trained subjects using a scale from 0 (no difference to the ethanol control) to 4 (much better odor reduction compared to the ethanol control).
  • a 0.5% strength by weight solution of anethole (raw material with a maximum of 0.5% by weight of cis-anethole, based on the weight of the total anethole) in ethanol was found to reduce sweat odor compared to the ethanol control by 2.42 units as particularly effective.
  • Anethole is characterized by an intense anise smell, so that it is not suitable in larger quantities for most commercial deodorants, because a strong anise odor is not accepted by the consumer for a cosmetic product.
  • DL-menthol and eucalyptol at a concentration of 0.5% by weight in ethanol reduced the malodour by 1.67 and 0.92 units, respectively, as compared to ethanol alone as a control. Also for these individual substances, it is desirable not to use them alone in excessive concentration, so that their own odor does not dominate the smell of the entire composition in an undesirable manner.
  • the improved protection against body odor by the active compound combinations according to the invention was statistically significantly confirmed by a 2-week application test with 200 subjects.
  • propylene carbonate is meant 4-methyl-1,3-dioxolan-2-one.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions cosmétiques servant à réduire les odeurs corporelles, contenant a) au moins un composé alcoxybenzole de formule développée (I) comportant les radicaux R1 et R2, R1 étant choisi dans un groupe alkyle C1 – C8 et R2 étant choisi parmi un groupe alkyle C1 – C8 et un groupe alcényle C2 – C8 dans une quantité totale comprise entre 0,01 et 1% en poids, b) au moins un composé choisi parmi des époxydes monoterpène cycliques dans une quantité totale comprise entre 0,01 et 1% en poids et du menthol dans une quantité totale comprise entre 0,09 et 5 % en poids, ainsi que parmi des mélanges de ces constituants, c) 0 à 7 % en poids d'eau, d) un excipient cosmétiquement acceptable contenant au moins un constituant choisi parmi l'éthanol, une huile cosmétique liquide dans des conditions normales et du talc, ainsi que des mélanges de ces constituants, et éventuellement d'autres excipients, additifs et principes actifs, les pourcentages en poids se rapportant au poids total de la composition, sans tenir compte des agents propulseurs éventuellement présents.
EP12791151.9A 2011-11-23 2012-11-20 Compositions déodorantes Withdrawn EP2782551A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011086923A DE102011086923A1 (de) 2011-11-23 2011-11-23 Deodorierende Zusammensetzungen
PCT/EP2012/073029 WO2013076050A1 (fr) 2011-11-23 2012-11-20 Compositions déodorantes

Publications (1)

Publication Number Publication Date
EP2782551A1 true EP2782551A1 (fr) 2014-10-01

Family

ID=47226146

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12791151.9A Withdrawn EP2782551A1 (fr) 2011-11-23 2012-11-20 Compositions déodorantes

Country Status (4)

Country Link
US (1) US20140248227A1 (fr)
EP (1) EP2782551A1 (fr)
DE (1) DE102011086923A1 (fr)
WO (1) WO2013076050A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2918295B1 (fr) * 2014-03-11 2018-01-17 Symrise AG Dispositif de libération de parfums avec indicateur de fin de vie
DE102014225434A1 (de) * 2014-12-10 2016-06-16 Henkel Ag & Co. Kgaa Mittel und Verfahren zur kosmetischen Behandlung
FR3029777B1 (fr) * 2014-12-15 2019-11-29 L'oreal Utilisation de l'association d'un polyether polyurethane non-ionique associatif et d'un derive de cyclohexanol comme agent rafraichissant de la peau
CN116194073A (zh) 2020-07-21 2023-05-30 化美有限责任公司 二酯化妆品制剂及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US5002970A (en) * 1981-07-31 1991-03-26 Eby Iii George A Flavor masked ionizable zinc compositions for oral absorption
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6383475B1 (en) * 1999-04-16 2002-05-07 Fd Management, Inc. Breath freshening lipstick
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
KR20060026362A (ko) * 2004-09-20 2006-03-23 (주)바스 기능성 항균 및 탈취 조성물
ATE501719T1 (de) * 2005-08-12 2011-04-15 Procter & Gamble Methoden und zusammensetzungen zur beruhigung von mund- und nasenschleimhäuten
EP2014273A1 (fr) * 2007-06-14 2009-01-14 Symrise GmbH & Co. KG Utilisation d'éther de menthyl méthyl et autre éther pour apporter d'une sensation de propreté et de pureté

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2013076050A1 *

Also Published As

Publication number Publication date
US20140248227A1 (en) 2014-09-04
WO2013076050A1 (fr) 2013-05-30
DE102011086923A1 (de) 2013-05-23

Similar Documents

Publication Publication Date Title
EP2785309B1 (fr) Spray aérosol cosmétique à effet rafraîchissant durable
DE102012222692A1 (de) Antibakterielles Kosmetikum
EP2651521A2 (fr) Compositions anti-transpirantes aqueuses à masquage amélioré des sels résiduels
DE102009002098A1 (de) Wasserfreie Antitranspirant-Sprays mit verbesserter Wirkstofffreisetzung
DE102009027604A1 (de) Kosmetische Zusammensetzungen mit Suspensionen von Silbersalzen
DE102009002097A1 (de) Antitranspirant-Sprays mit Esterölen
WO2013041611A1 (fr) Formulations anhydres présentant un effet de refroidissement
DE102011086019A1 (de) Deodorant- und Antitranspirant-Zusammensetzungen zur Verhinderung von Körpergeruch
EP2480192B1 (fr) Anti-transpirants non aérosol sans eau à libération améliorée d'agents
DE102017223179B4 (de) Rückstandsminimierte schweißhemmende Zusammensetzung mit verbessertem Hautgefühl
WO2013076050A1 (fr) Compositions déodorantes
DE102011084155A1 (de) Deodorierende Wirkstoffkombinationen
DE102009027050A1 (de) Antitranspirant-Sprays
WO2010145921A2 (fr) Compositions cosmétiques contenant des sels d'argent sélectionnés
WO2014187576A1 (fr) Association de principes actifs désodorisante
DE102015224559B4 (de) "Textil schonende Antitranspirant-Zusammensetzungen"
DE102011088967A1 (de) Deodorants und Antitranspirants mit stabilisiertem Antioxidans
DE102017223178A1 (de) Wasserfreie, schweißhemmende Zusammensetzung mit verbesserter Stabilität
EP3057566A1 (fr) Agent cosmétique anti-transpirant contenant des acides polyphosphoriques
EP2705879B1 (fr) Mélange d'huile pour compositions anti-transpirantes à masquage amélioré des sels résiduels
WO2010145922A2 (fr) Compositions anti-transpirantes contenant du citrate d'argent
EP3028744B1 (fr) Spray aerosol cosmetique ayant un effet de fraicheur
EP3057568A1 (fr) Agent cosmétique anti-transpiration contenant des acides alkylsulfoniques
DE102011087980A1 (de) Deodorants und Antitranspirants mit Haar aufhellender Wirkung
EP2442781B1 (fr) Compositions cosmétiques contenant du sulfate d'argent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20160912

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170124